ReportWire

Tag: Northwestern University

  • Northwestern agrees to $75 million fine to settle Trump dispute

    Northwestern University will pay a $75 million fine to settle allegations of antisemitism from the Trump administration, restoring hundreds of millions of federal funding, officials announced Friday.

    As part of the agreement, Northwestern also said it will continue following federal anti-discrimination laws, review its international admission policies and terminate an agreement reached with pro-Palestinian demonstrators last year.

    The nearly $800 million in federal research funding was abruptly paused in April. The money is expected to be fully restored within 30 days, according to a statement from Northwestern University interim President Henry Bienen.

    “This is not an agreement the University enters into lightly, but one that was made based on institutional values,” Bienen said. “As an imperative to the negotiation of this agreement, we had several hard red lines we refused to cross: We would not relinquish any control over whom we hire, whom we admit as students, what our faculty teach or how our faculty teach.”

    Other universities have agreed to pay fines to restore federal funding, as President Donald Trump pressures institutions to align with his political priorities. He has particularly criticized elite universities as hubs of antisemitism and progressive culture.

    Northwestern’s $75 million settlement, to be paid over three years, is the second-highest amount agreed to by a university. In August, Columbia University pledged to pay $200 million in a similar deal.

    “Today’s settlement marks another victory in the Trump Administration’s fight to ensure that American educational institutions protect Jewish students and put merit first,” Attorney General Pamela Bondi said in a statement. “Institutions that accept federal funds are obligated to follow civil rights law — we are grateful to Northwestern for negotiating this historic deal.”

    The deal will allow Northwestern to draw on all research funding, including overdue payments, lift any stop-work orders on non-terminated grants and protect the university’s eligibility for future grants. It will also close all pending investigations from the Department of Education, Department of Justice and the Department of Health and Human Services related to anti-discrimination laws and race-based admissions.

    As part of the agreement, Northwestern also said it would commit to Title IX — which prohibits sex-based discrimination —  by providing single-sex housing and locker room facilities for women upon request.

    Additionally, it will review its international admissions and develop training “to socialize international students to the norms of a campus dedicated to inquiry and open debate,” Bienen said. To ensure compliance, Northwestern said it will establish a committee on its board of trustees dedicated to the agreement.

    The paused funds had sent shockwaves through Northwestern’s research infrastructure beginning in April. As administrators scrambled to cover expenses, they resorted to a string of budget cuts — including hundreds of layoffs this summer.

    The intense federal pressure led to the abrupt resignation of former President Michael Schill in September. Schill had faced an onslaught of conservative criticism since last year over his handling of Northwestern’s pro-Palestinian encampment and the resulting agreement he reached with demonstrators.

    Northwestern University President Michael Schill resigns amid funding freeze

    In its deal with the Trump administration, Northwestern said it would terminate that agreement.

    Kate Armanini

    Source link

  • Northwestern University to pay $75 million to federal government to settle antisemitism claims, restore frozen funds

    Northwestern University will pay $75 million to the federal government over the next three years to end an antisemitism investigation by the Trump administration and restore hundreds of millions of dollars in frozen funds.

    The agreement was announced Friday night by the university and the Trump administration, which froze $790 million in federal funds for Northwestern in April, accusing the school of fostering antisemitism on campus.

    “Today’s settlement marks another victory in the Trump Administration’s fight to ensure that American educational institutions protect Jewish students and put merit first,” Attorney General Pamela Bondi said in a statement. “Institutions that accept federal funds are obligated to follow civil rights law — we are grateful to Northwestern for negotiating this historic deal.”  

    The university said it expects to have all of the federal funding that was frozen fully restored within 30 days as part of the settlement.

    In addition to the $75 million payment to the federal government, Northwestern also agreed to review its international admissions and develop training for international students to learn the “norms of the campus,” and reaffirm steps to protect Jewish members of the community.

    In a statement, Northwestern Interim President Henry Bienen defended the settlement agreement, noting it fought to keep full control over hiring, admissions, and curriculum as part of the deal.

    “As an imperative to the negotiation of this agreement, we had several hard red lines we refused to cross: We would not relinquish any control over whom we hire, whom we admit as students, what our faculty teach or how our faculty teach. I would not have signed this agreement without provisions ensuring that is the case,” Bienen wrote. “Northwestern runs Northwestern. Period.”

    In August, a group of Northwestern faculty wrote an open letter to school leadership, asking them not to make a deal with the Trump administration in order to restore the frozen federal funding.

    “Acquiescence to the administration’s tactics would make Northwestern complicit in an assault on higher education, which is an essential bulwark of civil society. The administration is skirting legal processes and demanding what amounts to ransom from universities; such actions continue its well-documented and dangerous abuse of executive power,” they wrote.

    Since the federal funding freeze, Northwestern has announced a hiring freeze, cutbackslayoffs and program and benefits changes to cope with its budget shortfall. Former Northwestern University President Michael Schill resigned in September amid the fallout from the funding freeze and antisemitism investigation.

    Several other major universities also have reached deals with the Trump administration in recent months to settle claims of antisemitism and other discrimination on campus.

    Columbia University in New York agreed to a $200 million settlement in July, to be paid out over three years to resolve investigations into alleged violations of anti-discrimination laws. Columbia also agreed to an additional $21 million to settle investigations from the U.S. Equal Employment Opportunity Commission. 

    Cornell University in New York agreed earlier this month to pay $30 million to the federal government to put an end to an investigation into claims of antisemitic harassment and discrimination amid campus protests over the war in Gaza. Cornell also agreed to invest $30 million in U.S. agriculture research.

    Brown University also cut a deal with the Trump administration to restore grant funding in exchange for commitments on women’s sports, antisemitism, admissions practices and a donation of $50 million to workforce development programs.

    The University of Pennsylvania also recently reached a deal with the Trump administration over their policy on transgender athletes in women’s sports.

    Source link

  • A mild symptom was bothering a young dad. He had Stage IV lung cancer.

    Endurance athlete Kevin Humphrey was used to discomfort. He regularly participated in ultramarathons and other intense events. Swimming, biking and running dozens of miles at a time was standard for him. His two young sons also kept him active even when he wasn’t training. But in January 2024, a persistent back pain kept bothering him. 

    The pain “just would not go away,” Humphrey said. He couldn’t sleep on his back. At the same time, he started coughing. He was diagnosed with pneumonia, but his symptoms lingered even after treatment. A chest CT scan found “something going on” in his left lung. A biopsy of the organ came back inconclusive, Humphrey said, but he kept pushing for answers. 

    “I knew something was off. It just didn’t feel right,” Humphrey said. 

    Humphrey traveled from Michigan to Chicago to seek a second opinion at Northwestern Medicine in May 2024. A bronchoscopy found shocking results: There was a tumor in his lung that was crushing the left side of his windpipe, causing the coughing and pain. 

    “I was really in disbelief,” said Humphrey, who had never smoked and had no family history of lung cancer. “It wasn’t even on my radar as a possibility. It wasn’t even an option in my mind.”  

    Kevin Humphrey. 

    Kevin Humphrey


    “A very concerning and dire situation” 

    Humphrey was diagnosed with Stage IV non-small cell adenocarcinoma, joining the growing number of young, non-smoking patients diagnosed with lung cancer. The rise may be driven by environmental or lifestyle factors, Dr. Jonathan Villena-Vargas, a thoracic surgeon at NewYork-Presbyterian and Weill Cornell Medicine, previously told CBS News. Villena-Vargas, who did not treat Humphrey, said there is no definitive reason for the increase. 

    Further tests found that the cancer had spread beyond Humphrey’s lung and had likely been growing for at least a year, Humphrey said. The disease typically has a 37% 5-year survival rate at that point, according to the Cleveland Clinic

    Humphrey’s tumor was “pretty advanced” and too large for surgery at first, said Dr. Daniel Dammrich, the Northwestern Medicine oncologist who treated him. But doctors were able to identify a “driver mutation” that was encouraging the cancer’s growth. These mutations are more common in young, non-smoking patients, Villena-Vargas said. 

    Identifying the mutation “really opened the door for some of our more nuanced, targeted therapies,” Dammrich said, and “turned a very concerning and dire situation into a much more optimistic one.”  

    Dammrich and Humphrey agreed on an aggressive plan that would combine targeted immunotherapy with chemotherapy, in the hopes that the medications would shrink the tumor enough for surgery. Humphrey began immunotherapy immediately, then had chemotherapy in summer 2024. By August, the cancer was operable.   

    img-4760.jpg

    Kevin Humphrey receives chemotherapy at Northwestern Medicine.

    Kevin Humphrey


    “The biggest question mark”   

    Removing the cancer meant taking out about half of Humphrey’s left lung. The athlete wasn’t sure what that would mean for his passion. 

    “You just had no idea. Can you run again, can you bike, can you do all these endurance sports that I’ve loved doing?” Humphrey said. “That was the biggest question mark going into surgery.” 

    Despite the unknowns, he focused on the future. Michigan’s Ironman 70.3 race — which included a 1-mile swim, 56.1-mile bike ride and a 13.2 mile run — was scheduled to take place a year and a day after his surgery. Humphrey decided to sign up, despite his fears. 

    img-4764.jpg

    Kevin Humphrey in the hospital.

    Kevin Humphrey


    Humphrey had surgery in mid-September. The operation removed most of the cancer, Dammrich said. Recovery was its own battle. Broken ribs and a “pretty big” incision made it difficult for Humphrey to do simple tasks like get out of bed or walk more than a few steps. Running was out of the question for months. But he kept putting one foot in front of the other until his strength and endurance began to slowly return. Even on the hardest days, the upcoming race kept him motivated. 

    “It was a great mental thing to put on the calendar and train for,” Humphrey said.

    “Across the finish line” 

    On Sept. 14, Humphrey was one of over 1,600 athletes who took part in the Ironman. He finished in just under five and a half hours, coming in 411th place. The race was exhausting and emotional, Humphrey said. 

    “You’re replaying everything that’s happened over the past year and the whirlwind it’s been,” Humphrey said. “For me, when I got to the point of knowing ‘I’m going to finish this race’ and thinking about my young boys, my wife, the family and the community and support system we’ve had throughout the whole year, and how grateful I am to not only be here but to continue to do these types of races and events. I certainly did not think that was going to be the case when I received the diagnosis in May of ’24.” 

    screenshot-2025-11-05-at-12-07-08-pm.png

    Kevin Humphrey’s son gives him a high-five during the Ironman 70.3 Michigan.

    Kevin Humphrey


    Humphrey’s medical situation is also positive. He had a complete response to the treatment, and there is currently no evidence of disease in his body, Dammrich said. Regular CT scans and blood tests watch for any new tumor growth. Humphrey remains on immunotherapy with few side effects. 

    On Oct. 12, less than a month after the Ironman, Humphrey ran the Chicago marathon for the sixth time. Over 53,000 runners participated in the race. Humphrey placed 25,395th, finishing in about seven and a half hours. It was “40 or 45 minutes slower” than when he ran the same race in 2023, Humphrey said, but he was proud to have finished. 

    “My goal was just to get across the finish line, and that’s what we did,” Humphrey said. “I was just grateful for the ability to be out there and to run and be doing the things that I’ve loved doing for such a long time.” 

    screenshot-2025-11-05-at-12-06-23-pm.png

    Kevin Humphrey’s sons cheer him on during the Chicago marathon.

    Kevin Humphrey


    Source link

  • How a broken limb led to a non-smoker’s lung cancer diagnosis a decade later

    Leslie Stoll developed a blood clot that led to a pulmonary embolism after she broke her leg in 2014. The embolism was treated, but another occurred when Stoll had surgery on her foot years later. After the treatment, she was referred to a hematologist who could prescribe blood thinners and monitor the clot. 

    At an appointment in 2024, the hematologist recommended a CT scan. It showed a small anomaly in her lungs. Stoll wasn’t worried: She was an athlete and former boxer who had never smoked. Her lung function felt normal.

    “I tried to reassure him that it was nothing, and it was probably something that was damaged from my pulmonary embolism, and he didn’t think I was very good at diagnosing myself,” Stoll told CBS News. “He was like, ‘Well, it probably is nothing, but let’s schedule a PET scan, just to check.’” 

    Stoll scheduled the test, but still doubted there was anything wrong, even telling the exam tech that she believed she was just going through the motions. Shortly after the scan, results saying that “malignancy could not be ruled out” were uploaded to an online patient portal. Then Stoll’s doctor called and asked her to come in the next day. Stoll’s doctor recommended a lung biopsy. 

    Leslie Stoll runs a race at Disney World in 2023, one year before her diagnosis.

    Leslie Stoll


    The biopsy revealed that Stoll had Stage One lung cancer, becoming one of the small but rising number of people diagnosed with the disease despite never smoking. 

    “I was just shocked at the fact that it could happen to me, disappointed that it could happen to me,” Stoll said. “I would love to have gone through life thinking I was immune to cancer, that it couldn’t get me. This was a big awakening that I might check ‘very healthy’ on my doctor’s forms when I go in every year, but all of a sudden I was not very healthy.”

    Lung cancer in “never-smokers”

    Dr. Jonathan Villena-Vargas, a thoracic surgeon at NewYork-Presbyterian and Weill Cornell Medicine, told CBS News in February that non-smokers with lung cancer are more common than people might expect. “Never-smokers” account for about 20% of the 250,000 new lung cancer diagnoses each year, said Villena-Vargas, who was not involved in Stoll’s care. 

    Dr. Lucas Delasos, an oncologist at the Cleveland Clinic who did not treat Stoll, said women, particularly those of Asian descent, are more likely to be diagnosed with lung cancer despite never smoking. 

    Younger non-smoking patients are also more likely to have mutations that drive the disease’s growth, Delasos said. Identifying those mutations allows for more personalized treatment. 

    Some of the increase in diagnoses may come from an increased awareness, Delasos said. A spot that might have been ignored or missed by earlier technology is now more likely to be tested and diagnosed, he said. Researchers are also studying environmental factors, like radon gas or other hazardous materials.  

    img-1942-leslie-stoll.jpg

    Leslie Stoll at Northwestern Medicine. 

    Leslie Stoll


    “Too young to not be aggressive”  

    Stoll was referred to Dr. Andrew Arndt, a thoracic surgeon at Northwestern Medicine. He encouraged her to treat the cancer with a robotic surgery that would remove a section of her right lung’s lower lobe. 

    Stoll worried the operation would impact her ability to exercise or take part in daily life. To reassure her, Arndt sketched her lung and drew what the minimally invasive operation would entail. 

    “He said I was too young to ignore this, I was too young to not be aggressive with it,” Stoll said. She agreed to the surgery. 

    screenshot-2025-10-23-at-7-47-16-pm.png

    Dr. Andrew Arndt’s sketch of Leslie Stoll’s lung.

    Leslie Stoll


    During the procedure, Arndt biopsied Stoll’s lymph nodes to confirm the cancer hadn’t spread. The tests were negative, meaning Stoll didn’t have to undergo chemotherapy or radiation treatment. 

    Further tests found that she had no evidence of cancer after the surgery, Arndt said.

    “I was able to get my life back”  

    Recovery felt harder than surgery, Stoll said. Before, she had easily been able to run for miles at a time. The day after the operation, Stoll “could barely walk down the hall.” Being unable to exercise as usual felt like the cancer “took away some of my personality,” Stoll said. 

    As the days ticked by, Stoll slowly improved. She went from trudging down the hall to taking long walks in her neighborhood. Hills became less of a struggle. When she was cleared for full activity, she celebrated with a “very slow” run. Nine months after the surgery, she climbed Phoenix’s Camelback Mountain, a difficult trek that can take up to three hours. 

    “I was just determined to take some action to get back to my old self as soon as possible,” Stoll said. 

    screenshot-2025-10-23-at-7-56-46-pm.png

    Leslie Stoll hiking Camelback Mountain. 

    Leslie Stoll


    Now, about six months after her surgery, Stoll is back to her regular life. She works out and walks her dog twice a day. Arndt’s drawing of her lung sits on her mantle as a reminder of what she went through. She has regular scans to make sure the cancer has not returned. Stoll said she is careful to attend all of her follow-up appointments, aware that those precautions were key to diagnosing her cancer early. 

    “I was able to stop my cancer from taking control of my life, and I was able to get my life back,” Stoll said. “If I had never gone to that follow-up appointment, then I might still have cancer growing inside me.” 

    Source link

  • Group faces loss of student status for refusing Northwestern’s mandatory training; judge denies TRO

    EVANSTON, Ill. (WLS) — Northwestern University says as many as 16 students face the loss of their student status at midnight for refusing that mandatory training, a request to block that action denied by a federal judge.

    The students, their attorneys and their supporters left court disappointed but defiant.

    ABC7 Chicago is now streaming 24/7. Click here to watch

    “We believe in our claims. We believe in our clients, and we believe that our claims are meritorious and that the courts will agree at the end of the day,” said attorney Maria Nieves Bolaños.

    A group of students is suing Northwestern, alleging that the school’s anti-bias training and policies “prohibit expressions of Palestinian identity” by characterizing “criticism of the state of Israel as antisemitic.”

    “Certain expressions of national origin are permitted at Northwestern and certain are not, and this policy prohibits a specific expression of national origin,” said attorney Rima Kapitan.

    The university says at least 16 students have refused the training and now face the loss of their student status at midnight. The plaintiffs sought a temporary restraining order in federal court, but a judge denied that request, finding Northwestern did not engage in discrimination.

    In fact, the school’s attorneys argued that the training is meant to prevent discrimination and harassment and cited a quote from the training that states “it is not antisemitic to criticize the policies, practices or members of the Israeli government.”

    The lawsuit comes as the Trump administration has frozen nearly $800 million in federal funding to Northwestern over alleged civil rights violations related to the school’s handling of pro-Palestinian encampments in April 2024.

    “Rather than stand up for the core mission of higher education, Northwestern has bent its knee to the Trump administration,” said Jonah Rubin with Jewish Voices for Peace.

    Northwestern declined to comment on the lawsuit, saying it does not speak about pending litigation.

    Copyright © 2025 WLS-TV. All Rights Reserved.

    Eric Horng

    Source link

  • Mom, 37, diagnosed with cancer after push for early screening:

    Michaela Del Barrio had always known that her family history of breast cancer meant she had a higher risk than most of being diagnosed with the disease.

    In her 20s, doctors had told her she was too young to dwell on those concerns. However, after the birth of her second child, she began to worry more about her odds. 

    One day, during a standard doctor’s appointment, Del Barrio asked her doctor if there were any options for her to start receiving mammograms early. Her physician directed her to Northwestern University’s high-risk breast clinic. After a risk assessment, she had her first mammogram at 36 years old. The exam was clear but the clinic’s assessment also allowed her to undergo a breast MRI. 

    “A week later, I got a call saying they had seen two suspicious masses in my left breast,” Del Barrio said. “I was just stunned. I just didn’t even know how to process that.” 

    Michaela Del Barrio and her family at a wedding in 2025. 

    Michaela Del Barrio


    Del Barrio had an ultrasound and a biopsy. In mid-February, she was diagnosed with early-stage breast cancer. She had never had any symptoms or felt a lump. Del Barrio said she still thinks “all the time” about what could have happened if she had not pushed to receive early screenings

    “You’re doing all the steps to take care of your health and prioritize yourself. You don’t expect to receive a call that you have cancer,” Del Barrio said. “But now I think ‘Thank goodness I did speak up for myself. Thank goodness I did it when I did it, and that I didn’t wait.’”

    “Throwing everything at it” 

    Del Barrio was diagnosed with invasive ductal carcinoma, a form of breast cancer that grows in the breast’s milk ducts. It’s the most common type of breast cancer, making up about 80% of breast cancer diagnoses, according to the National Breast Cancer Foundation.  

    Del Barrio’s treatment started with surgery. Because the cancer had been caught early, it had not spread beyond her left breast, said her oncologist, Dr. Annabelle Veerapaneni. Del Barrio decided to undergo a bilateral mastectomy to limit her odds of the cancer returning in the future. After the surgery was complete, an analysis of Del Barrio’s tumors determined that she would likely benefit from chemotherapy. 

    4-16-just-finished-my-double-mastectomy-surgery-at-northshore.jpg

    Michaela Del Barrio after undergoing a double mastectomy.

    Michaela Del Barrio


    “I was like, ‘I’m young. I want to make sure I’m doing everything and throwing everything at it for it to not come back,’” Del Barrio said. 

    The mother of two started chemotherapy in the summer of 2025. She was supposed to receive four rounds of treatment but had to stop after three because she experienced a delayed allergic reaction that caused her to break out in hives. 

    “I know that she was very anxious about not receiving that final fourth cycle of treatment but I told her that the risk of exposure to that particular chemotherapy agent was too high based upon the clinical benefit,” Veerapaneni said. “So we had a very long heart-to-heart about everything, and I gave her reassurance that she finished the majority of the planned chemotherapy, and she’s recovered very, very well.”

    photo-aug-06-2025-9-39-29-am.jpg

    Michaela Del Barrio receives chemotherapy.

    Michaela Del Barrio


    Diagnosing breast cancer early

    Women with an average risk of breast cancer are recommended to start receiving mammograms when they turn 40. Still, those at higher risk should start earlier, said Dr. Arif Kamal, an oncologist and the American Cancer Society’s chief patient officer. Breast cancer is on the rise in women under 50, CBS News previously reported

    Kamal said patients need to be aware of their personal risk of cancer. That includes being aware of any family history of cancer and undergoing appropriate screenings

    “One in 10 women are not at average risk, and for them, they need a different plan,” Kamal said.

    That might mean early mammograms or breast MRIs, like it did for Del Barrio, or more frequent exams. It could also include genetic testing, Kamal said. Kamal recommended women begin speaking to their doctors in their mid-20s, and flag any family history of cancer to develop the best course of action. 

    Veerapaneni said she “shudders to think” how much worse Del Barrio’s case could have been. According to the National Breast Cancer Foundation, early-stage invasive ductal carcinoma has a five-year survival rate of 99%, but that number falls as the disease spreads. The most advanced stage of the cancer has a five-year survival rate of just 32%.  

    “I really give Michaela a lot of credit for being self-aware and self-advocating,” Veerapaneni said. 

    “One day at a time” 

    Del Barrio is currently undergoing an extended endocrine therapy treatment that involves a monthly injection and a daily pill that eliminates estrogen production in her body, Veerapaneni said. Del Barrio will stay on the regimen for 10 years because of how young she was when her cancer was diagnosed. The treatment will “significantly reduce” the risk of her cancer returning, Veerapaneni said. 

    Del Barrio will also undergo regular scans and long-term follow-up with Veerapaneni. She said she will also have reconstructive breast surgery at the end of the year. 

    8-2-family-photo-halfway-done-with-chemo-and-still-have-hair.jpg

    Michaela Del Barrio and her family in August.

    Michaela Del Barrio


    “I always say, ‘This part is not so bad.’ I can be a good patient, and I can follow all the instructions, the medicine, and focus on the task at hand,” Del Barrio said. “I just focus on it one day at a time.” 

    Del Barrio said that hopefully life will become “more routine” after her reconstruction, and allow her space to process what she has been through in the past year. 

    “It’s overwhelming. You get this life-changing diagnosis, but also, life just is completely normal at the same time,” Del Barrio said. “I feel like I’m just managing another project in my life, which is cancer.” 

    Source link

  • Leaders of Rutgers, Northwestern, UCLA to testify before Congress on Pro-Palestinian campus protests

    Leaders of Rutgers, Northwestern, UCLA to testify before Congress on Pro-Palestinian campus protests

    What to Know

    • House Republicans have summoned the leaders of Northwestern University and Rutgers University to testify about concessions they gave to pro-Palestinian protesters to end demonstrations on their campus.
    • The chancellor of the University of California, Los Angeles, also was scheduled to appear Thursday in the latest in a series of hearings by the House Committee on Education and the Workforce into how colleges have responded to the protests and allegations of antisemitism.
    • Tensions over the Israel-Hamas war have been high on campuses since the fall and spiked in recent weeks with a wave of pro-Palestinian tent encampments that led to over 3,000 arrests nationwide.

    House Republicans have summoned the leaders of Northwestern University and Rutgers University to testify about concessions they gave to pro-Palestinian protesters to end demonstrations on their campus.

    The chancellor of the University of California, Los Angeles, also was scheduled to appear Thursday in the latest in a series of hearings by the House Committee on Education and the Workforce into how colleges have responded to the protests and allegations of antisemitism. Tensions over the Israel-Hamas war have been high on campuses since the fall and spiked in recent weeks with a wave of pro-Palestinian tent encampments that led to over 3,000 arrests nationwide.

    After the first of those hearings in December, an outcry of criticism from donors, students and politicians led to the resignations of the presidents of Harvard and the University of Pennsylvania, who gave cautious, halting answers to questions about whether calls for the genocide of Jews would violate their schools’ conduct policies.

    In April, the committee turned its attention to Columbia President Minouche Shafik, who took a more conciliatory approach to Republican-led questioning. Shafik’s disclosure of disciplinary details and concessions around faculty academic freedom upset students and professors at Columbia. Her testimony, and subsequent decision to call in police, escalated protests on campus that inspired students at other colleges to launch similar demonstrations.

    Thursday’s hearing expands the scope of the committee’s inquiry for the first time to large, public universities, which are more strictly governed by First Amendment and free speech considerations. Earlier hearings largely focused on private, Ivy League colleges.

    Originally, the presidents of Yale University and the University of Michigan were called to testify. But the committee shifted its attention to Northwestern and Rutgers after those colleges struck deals with pro-Palestinian protesters to limit or disband encampments.

    Expected to testify Thursday are Michael Schill, the president of Northwestern; Gene Block, UCLA’s chancellor; and Jonathan Holloway, the president of Rutgers.

    The concessions that Northwestern and Rutgers agreed to were limited in scope. Like some other colleges that reached agreements with protesters, they focused on expanding institutional support for Muslim and Arab students and scholars on campus.

    At Northwestern, the administration agreed to re-establish an advisory committee on its investments that includes student, faculty and staff input. The university also agreed to answer questions about financial holdings including those with ties to Israel.

    Rutgers agreed to meet with five student representatives to discuss the divestment request in exchange for the disbanding of the encampment. The university also stated it would not terminate its relationship with Tel Aviv University.

    The committee’s chair, Rep. Virginia Foxx, R-N.C., criticized the schools for their decision to negotiate with protesters.

    “The Committee has a clear message for mealy-mouthed, spineless college leaders: Congress will not tolerate your dereliction of your duty to your Jewish students,” she said in a statement. “No stone must go unturned while buildings are being defaced, campus greens are being captured, or graduations are being ruined.”

    UCLA’s oversight of its campus protests has been under scrutiny since counter-demonstrators with Israeli flags attacked a pro-Palestinian encampment on campus. The counter-demonstrators threw traffic cones and released pepper spray in fighting that went on for hours before police stepped in, drawing criticism from Muslim students and political leaders and advocacy groups.

    On Wednesday, the police chief at UCLA was reassigned “pending an examination of our security processes,” according to a statement from the school.

    Annie Ma

    Source link

  • 2 Universities Have Now Reached Deals With Pro-Palestine Protesters To End Encampments

    2 Universities Have Now Reached Deals With Pro-Palestine Protesters To End Encampments

    Northwestern University in Illinois and Brown University in Rhode Island both reached a deal with pro-Palestine protesters this week to end their occupation of campus grounds.

    College and universities across the U.S. have been flooded with student demonstrations in the past several weeks against Israel’s attacks on Gaza, in some cases pressing their schools to divest from companies linked to Israel. Many of the demonstrators, including those at Columbia University, have set up encampments on campus that have been met with police force, arrests and school suspensions.

    On Monday, Northwestern officials appeared to be the first to reach a deal with antiwar demonstrators, following five days of protests and encampments on Deering Meadow, the Daily Northwestern reported.

    As part of a bargain made by NU and the Northwestern Divestment Coalition, a group helping to organize the protests and encampment, the university agreed to permit protests and pro-Palestine gatherings through the final day of spring classes on June 1. The school has also agreed to disclose its investments in businesses with Israeli ties.

    In exchange, the NDC has agreed to leave just one aid tent on the lawn. University officials also stressed that students shouldn’t be punished for demonstrating by non-campus actors like employers.

    Signs are displayed outside a tent encampment at Northwestern University on Friday, April 26, 2024, in Evanston, Illinois.

    ″[The university] will advise employers not to rescind job offers for students engaging in speech protected by the First Amendment,” a university statement obtained by the Daily Northwestern said.

    In a statement, the Northwestern Divestment Coalition celebrated the victory.

    “For the first time, a university administration has committed to full disclosure of its holdings and investments in specific companies, including those whose investments support Israeli apartheid, as well as a clear path to the university’s divestment from those holdings,” the group’s statement said in part.

    On Tuesday, another deal was reached between Brown University and the Brown Divest Coalition, a similar pro-Palestine group. Protesters involved with the coalition agreed to remove all tents and end the encampment on campus in exchange for a promise from the university to hold a board vote in October on whether or not to divest from Israel-linked companies.

    Brown also agreed to invite five students chosen by the coalition for a meeting next month with school administrators to again discuss a 2020 proposal recommending divestments from companies linked to Israel. BU also said students and faculty who have engaged in demonstrations won’t be punished by the school.

    “No member of the Brown community ― including faculty, staff, graduate students, undergraduate students, or alumni ― found to have been involved in the encampment or related activity will face retaliation from the University, including termination of employment or reduction in salary,” the agreement from the university said.

    In a statement posted to Instagram, Brown Divest Coalition said the “victory is not the end to our work but rather fuel for it.”

    “We will continue to pressure Brown to ensure we divest in October and support encampments across the country,” the statement said in part. “We stand with student protesters as they face university oppression and police brutality, and the people of Palestine as they continue to withstand the Israeli occupation.”

    Source link

  • March Madness: Northwestern, Illinois among men’s basketball teams seeded in NCAA Tournament

    March Madness: Northwestern, Illinois among men’s basketball teams seeded in NCAA Tournament

    CHICAGO (WLS) — Northwestern University and the University of Illinois were among the teams Sunday who were selected and seeded for the March Madness college basketball tournament.

    Northwestern will be a No. 9 seed in the east region, playing No. 8 seed Florida Atlantic on Friday in Brooklyn, New York. Illinois will be a No. 3 seed in the east region, facing Moorhead State in a first-round game Thursday in Omaha, Nebraska.

    Most Northwestern Wildcats fans celebrating the announcement Sunday night at Welsh-Ryan Arena in Evanston said they were expecting to get in, and they can’t wait to keep cheering the team on.

    Just to see us in the dance for the second year in a row is incredible

    Will Klearman, Wildcats fan

    The Northwestern men’s basketball team is going dancing. For the first time in school history, the men’s team has clinched back-to-back NCAA Tournament appearances.

    The Northwestern men’s basketball team is going dancing. For the first time in school history, the team has clinched back-to-back NCAA Tournament appearances.

    Fans of all ages packed Welsh-Ryan Arena to take in the moment with the team.

    “I mean it’s incredible… it’s a blessing,” Northwestern fan Will Klearman said. “I’ve been coming to these games since I was four years old, and just to see us in the dance for the second year in a row is incredible.”

    Fans at the watch party didn’t have to wait long for the celebration as Northwestern’s matchup was quickly announced as the second matchup to open the selection show.

    “Very quick… not much time before the confetti started to fall, which was great,” Northwestern fan Elliot Kadar said.

    Some fans were never worried.

    “We knew we were making it,” Northwestern fan Yosef Bolkowitz said. “There was no sweating.”

    It has been a special year for the Wildcats, with the team upsetting some of the top teams in the nation during the regular season.

    SEE ALSO | Wrigleyville Draft Kings bar begins in-person sports betting just in time for March Madness

    Members of the team took time to sign autographs for kids after the announcement. The community continues to rally around the school.

    “It’s a great experience,” team equipment manager Jaren McGee said. “Northwestern back-to-back years in the NCAA Tournament… never happened before, so we’re happy to do this and bring our fans out, and experience this as well. It’s been great.”

    Fans know a tough road is ahead as the reigning national champs at UConn are in their region, but there’s no shortage of confidence as March Madness begins.

    “I’m happy. Go cats!” Northwestern fan Jayden Wharton said. “It’s our year, we’re winning the natty. Let’s go!”

    Defending champion Connecticut, along with Houston, Purdue and North Carolina, are the top seeds in a March Madness bracket that started going haywire even before the pairings came.

    Of the four top seeds, only UConn heads into the tournament coming off a win. That played into the Huskies receiving the No. 1 overall seed. The other three top seeds lost in their conference tournaments.

    The Associated Press contributed to this report.

    Copyright © 2024 WLS-TV. All Rights Reserved.

    Maher Kawash

    Source link

  • Northwestern roiled by criminal charges against two students who made parody copies of student paper

    Northwestern roiled by criminal charges against two students who made parody copies of student paper


    Divisions over the war in Gaza, questions about race as it relates to how the law is enforced, and what free speech means on campus are part of a controversy at Northwestern University and its student paper after two Black students were charged criminally for distributing a parody of the publication.

    Nearly 90 Northwestern students, professors and community members criticized the response to the incident late last week, calling it part of an effort to silence pro-Palestinian voices that disproportionately affect people of color.

    The two students were accused of distributing a parody of The Daily Northwestern and the consequences have many students and faculty calling it an overstep and a “symptom of the over-policing of Black students” on campus.

    The men, 20 and 22, were charged in December with theft of advertising services, a class A misdemeanor, according to Cook County court records. The records say they were released on the scene, but the charge is still pending.

    The men were the subject of the letter that identified them as Northwestern students who allegedly created an imitation front page of the campus newspaper that critiqued the university’s actions in connection to Israel’s bombardment of Gaza in response to last year’s Hamas terror attacks.

    An attorney representing the men declined to comment. They are scheduled to appear in court again Feb. 29 in the Skokie branch court.

    Cook County State’s Attorney Kim Foxx also declined to respond to messages seeking comment.

    “I think the approach to these two students was extremely aggressive and unnecessary,” said Mary Pattillo, professor of sociology and chair of the Department of Black Studies at Northwestern, who signed the letter. “This strikes me as very much in line with a country that has no other way to manage behavior other than criminalizing it.”

    On Oct. 25, students on campus could find a single-page flyer that looked similar to the popular student-run newspaper with the headline “Northwestern complicit in genocide of Palestinians” printed across its lower third.

    A court filing accuses the two men of attaching “an unauthorized replica of the Daily Northwestern Newspaper” to a previously distributed edition and placing copies in the newspaper stand.

    The charges say they did so “without a contractual agreement between the publisher and an advertiser.” Listed as the complainant is Stacia Campbell, general manager of Student Publishing Co.

    In a Monday statement, Student Publishing, parent company of The Daily Northwestern, said it reported the fake front page to campus police, which resulted in charges filed by the Cook County state’s attorney’s office.

    It noted that as a private entity, it does not have the ability to file or dismiss charges.

    “The content of the fake front page had no bearing on this decision,” the statement read.. “This is not an issue of speech or parody. A fake newspaper distributed on its own, apart from The Daily Northwestern, would cause no concern. But tampering with the distribution of a student  newspaper is impermissible conduct.”

    Evgeny Stolyarov, a second-year student of Middle East and North African studies, said when he first saw copies of the parody newspaper in his biology lecture hall on Oct. 25, he thought the move was “genius.”

    “I don’t think a single person who saw those thought it was the real ‘Daily Northwestern,’” Stolyarov said. “First of all, it was not called the ‘Daily Northwestern,’ but the ‘Northwestern Daily.’ The reaction wasn’t as big at the moment, and I don’t think anyone expected that it would be a Class A misdemeanor.”

    Stolyarov noted that the authentic newspaper’s print cycle is Mondays and Thursdays, and the parody was distributed on a Wednesday.

    “So no one was looking for the new copy and walked into this thinking, ‘Oh, I’ve been fooled!’” he said. “So to say that somehow this infringed on the rights of the journalists – who also released a statement saying that the charges should be dropped – I just think that all across the board, the arguments don’t add up.”

    In an editorial posted Feb. 5, The Daily Northwestern Editorial Board said they don’t support the criminal prosecution of the students responsible for the parody paper.

    “Our newspaper has always prided itself on its commitment to informing and supporting students, and we believe our publisher should play no part in perpetrating harm against the communities we aim to serve,” the editorial stated.

    “Our university and community — along with the American policing and justice system as a whole — has a long history of placing people of color in harm’s way. As a publication that strives to unearth these injustices through our reporting, we remain wholeheartedly opposed to any course of action that would entwine our publication with this harmful legacy.”

    Pattillo said, unfortunately, the approach taken doesn’t surprise her. The conflict has stirred controversy at elite universities across the country.

    “I think campuses are always forever challenged with how to approach the energies of their students,” she said. “In this moment where we might think about other approaches like restorative justice or, on a college campus, one might think of more dialogue – instead, this escalated to the criminal legal system.”

    Pattillo noted that this type of policing is what Black students organized against last year after the university announced it would use private security to remove them from campus buildings at night when Northwestern University Community Not Cops’ (NUCNC) protests to invest in Black students were met with pepper spray and arrests.

    “I think given that students of color are especially at the forefront of this particular social movement, and at the forefront of many social movements, it is the students who represent groups who experience oppression who rise up and protest,” Pattillo said.

    According to Pattillo, students of color facing a greater extent of the law is an issue seen on college campuses near and far.

    In November, a Palestinian American student at the University of Illinois at Chicago was handcuffed and arrested in a classroom and charged with criminal defacement for marking up property with messages supporting Palestine around campus.

    Though the charge was dismissed, students said the consequences were an overreach by the university.

    “We’ve had so many instances where UICPD has been aggressive to Muslim students for no reason,” said Celine Taki, a Syrian American junior at UIC, who was at a January rally calling for the firing of the campus police officers who carried out the arrest. “That girl was arrested just because she wrote Free Palestine on the wall. There’s been over 130 cases of vandalism on this campus, but only that one resulted in an arrest where she was detained.”

    According to the latest available UIC police records, the Palestinian American student is the only person to have been arrested for criminal defacement on campus.

    “On university campuses, it is always important to remember that we’re talking about 18- to 22-year-olds, sometimes 17- to 22-year-olds –  I think the most important approach is to think of the university as one large classroom and to treat all students as students and that this is their learning journey, and to approach them as learners and as teachers as well,” Pattillo added. “I do think that their activism is also instructive for their colleagues and for their faculty members and staff and administrators. That is the kind of approach that should be taken in these very, very tense and difficult moments.”

    Northwestern community members who penned the North by Northwestern letter are asking others to show support by adding their names to a Change.org petition demanding the charges be dropped.

    “The vast majority of the student body, whether it’s groups that are directly connected to Palestine or groups that have nothing to do with the movement, all agree that this will have a chilling effect on free speech,” said Stolyarov, who is a member of Jewish Wildcats for Ceasefire. “It’s nothing new that the university uses police brutality, especially against black students, so it was both shock and a sense that we’ve seen this before.”

    Ed Yohnka, a spokesman for the American Civil Liberties Union Illinois, said the charges feel like “a misuse of the statute” the pair was cited under.

    “These are college students that were engaging in a political protest, one might even describe it as a stunt to make a political point,” Yohnka said. “No one was meaningfully harmed as a result of this.”

    Yohnka noted that criminal charges could follow and potentially harm individuals for years and said the use of the statute in this instance raises concerns that criminal charges could be levied unequally based on the type of speech in question.

    “This is where the prosecutorial power that is going to be used feels a little off the mark in a use of taxpayer dollars,” he said.

     

     

     

     

     

     



    Zareen Syed, Madeline Buckley

    Source link

  • Ozempic Makes You Lose More Than Fat

    Ozempic Makes You Lose More Than Fat


    The newest and much-hyped obesity drugs are, at their core, powerful appetite suppressants. When you eat fewer calories than you burn, the body starts scavenging itself, breaking down fat, of course, but also muscle. About a quarter to a third of the weight shed is lean body mass, and most of that is muscle.

    Muscle loss is not inherently bad. As people lose fat, they need less muscle to support the weight of their body. And the muscle that goes first tends to be low quality and streaked with fat. Doctors grow concerned when people start to feel weak in everyday life—while picking up the grandkids, for example, or shoveling the driveway. Taken further, the progressive loss of muscle can make patients, especially elderly ones who already have less muscle to spare, frail and vulnerable to falls. People trying to slim down from an already healthy weight, who have less fat to spare, may also be prone to losing muscle. “You have to pull calories from somewhere,” says Robert Kushner, an obesity-medicine doctor at Northwestern University, who was also an investigator in a key trial for one of these drugs.

    Kushner worries about patients who start with low muscle mass and go on to become super responders to the drugs, losing significantly more than the average 15 to 20 percent of their body weight. The more these patients lose, the more likely their body is breaking down muscle. “I watch them very carefully,” he told me. The impacts of losing muscle may go beyond losing just strength. Muscle cells are major consumers of energy; they influence insulin sensitivity and absorb some 80 percent of the glucose flooding into blood after a meal. Extreme loss might alter these metabolic functions of muscle too.

    Exactly how all of this will affect people on Wegovy and Zepbound, which are still relatively novel obesity drugs, is too early to say. (You may have heard these same two drugs referred to as Ozempic and Mounjaro, respectively, which are their names when sold for diabetes.) These drugs cause a proportion of muscle loss higher than diet and exercise alone, though roughly on par with bariatric surgery. Lifestyle changes can blunt the loss, but pharmaceutical companies are on the hunt for new drug combinations that could build muscle while burning fat.

    The arrival of powerful weight-loss drugs has moved the field beyond simple weight loss, Melanie Haines, an endocrinologist at Massachusetts General Hospital, told me. That challenge is largely solved. Instead of fixating on the number of pounds lost, researchers, doctors, and ultimately patients can focus on where those pounds are coming from.


    Doctors currently offer two pieces of standard and unsurprising advice to protect people taking obesity drugs against muscle loss: Eat a high-protein diet, and do resistance training. These recommendations are perfectly logical, but their effectiveness against these drugs specifically is unclear, John Jakicic, a professor of physical activity and weight management at the University of Kansas Medical Center, told me. He is now surveying patients to understand their real-world behavior on these drugs.

    Fatigue, for example, is a common side effect. “When you’re tired, and you’re fatigued, do you really feel like exercising?” he said. Haines wonders the same about eating enough protein. The drugs are so good at suppressing appetite, she said, that some people might not be able to stomach enough food to get adequate protein. (Food companies have started pitching high-protein snacks and shakes to people on obesity drugs.)

    If patients stop taking Wegovy and Zepbound—and about half of patients do stop within a year, at least in real-world studies of people taking this class of drugs for diabetes—the weight regained comes back as fat more than muscle, says Tom Yates, a physical-activity professor at the University of Leicester. Muscle mass tends not to entirely recover. It’s “almost as if you’re better off staying where you are than going through cycles of weight loss,” he told me.

    Yet, he pointed out, the U.K. recommends Wegovy for a maximum of two years. In the U.S., patients who can’t afford the steep out-of-pocket price have been forced to stop when insurance companies abruptly cut off coverage or a manufacturer’s discount coupon expires. These policies are likely to trigger cycles of weight loss and gain that lead, ultimately, to net muscle loss.


    Meanwhile, drug companies are already thinking about the next generation of weight-loss therapies. “Wouldn’t it be great to have another mechanism that’s moving away from just appetite regulation?” Haines said. Companies are testing ways to preserve—perhaps even enhance—muscle during weight loss by combining Wegovy or Zepbound with a second muscle-boosting drug. Such a combination could, in theory, allow patients to lose fat and gain muscle at the same time.

    Years ago, scientists first became interested in potential muscle-enhancing drugs that mimic mutations found in certain breeds of almost comically ripped dogs and cattle. At the time, they hoped to treat muscle-wasting diseases. The drugs never quite worked for that purpose, but the trial for one such drug, an antibody called bimagrumab, found that patients also lost fat in addition to gaining lean mass. A start-up acquired the drug and began testing it for weight loss in combination with semaglutide, the active ingredient in Wegovy, or Ozempic. And last year, Eli Lilly, the maker of Zepbound, snapped up that company for up to $1.9 billion—in hopes of making its own combination therapy.

    Pairing bimagrumab with an existing obesity drug could potentially maximize the weight loss from both. Losing weight tends to get harder over time; as you lose muscle, your body burns fewer calories. A drug that minimizes that muscle loss—or even flips it into muscle gain—could help patients boost the amount of energy their body expends, while Wegovy or Zepbound suppresses calories consumed. The mechanisms of how this might actually work in the body still need to be understood, though. Previous studies of bimagrumab found that patients grew more muscle, but they didn’t necessarily become faster or stronger. Haines, who is planning a small study of her own with bimagrumab, is most interested in how the combination affects not the structural but the metabolic functions of muscle.

    Bimagrumab is the furthest along of several drugs that tinker with the same pathway for muscle growth. The biotech company Regeneron recently published promising data on two of its muscle-enhancing antibodies paired with semaglutide in primates; a trial in humans is due to begin later this year. The start-up Scholar Rock is testing another antibody called apitegromab. Other companies are interested in combining the obesity drugs with different potential muscle boosters that work by mimicking certain hormones such as apelin or testosterone. If they succeed, the next generation of drugs could help sculpt a more muscular body, not just a smaller one. Eating less can only do so much to better your health.



    Sarah Zhang

    Source link

  • Fans pack Northwestern women’s basketball game; Iowa star Caitlin Clark breaks Big 10 scoring record

    Fans pack Northwestern women’s basketball game; Iowa star Caitlin Clark breaks Big 10 scoring record


    EVANSTON, Ill. (WLS) — Fans lined up outside hours Wednesday at Northwestern University before tip off to get the best general admission seats to see the opposing team’s best player, Caitlin Clark.

    University of Iowa alum Greg Mittelan had the game circled on his calendar last fal, but getting tickets was a challenge.

    “She’s so exciting to watch. It’s awesome,” Mittelman said. “Single game was sold out so I made a snap decision, ‘I’m just gonna go for season tickets.’”

    The Iowa game is the first time Northwestern women’s basketball has ever sold out at Welsh Ryan Arena. It turns out a season ticket package was less expensive than a single game ticket for the game on the secondary market.

    Ticket brokers were selling the least expensive general admission tickets for more than $230 apiece.

    “I got calls from all over,” said Steve Buzil with Sit Close Tickets. “Never in my life sold tickets to this thing. She’s a phenom and deservedly so.”

    Clark is on the verge of becoming the all time leading scorer in college basketball, with both the women’s and men’s records in her sights.

    Her Iowa Hawkeyes are one of the favorites to win the national championship.

    Barrington High school coach Babbi Barreiro said Clark is a great role model for her players and all young women.

    “It’s just great. Great for women’s sports. Great for basketball, men’s or women’s I think,” Barreiro said.

    Northwestern will likely have it’s hands full with the matchup. They have a losing record so far this season, and with a 19-2 record, Iowa is ranked third in the country right now.

    Clark is no doubt the number one star in the sport right now.

    “She plays for Iowa, my mom went to Iowa and I’m going to go to Iowa, too,” said Brianna Favia, a young fan.

    The Hinsdale Central High School girls basketball team was screaming as the fan fever was high and in full supply at Welsh-Ryan Arena.

    “I like when she shoots from half court, like she crazy,” said Kayla Flores, a player on the Hinsdale Central High School Girl Basketball team. “Pulls up right there, drops it.”

    Clark is inspiring a new generation of aspiring women’s basketball players from Hinsdale Central.

    “Just watching her passion in the game, the way she just plays with her team,” said Mia Molis, a player on the Hinsdale Central High School Girl Basketball team.

    The Hawkeye guard has become the new face of women’s basketball.

    “I love watching her score and just everything about her,” said Brynley Sorce from Mount Prospect.

    Clark broke a record Wednesday, becoming the all-time leading scorer in Big 10 history, according to ESPN.

    Clark is approaching the all-time scoring record in women’s basketball of 3,527 points, held by Kelsey Plum.

    The Hawkeyes star has 3,389 points and is averaging 32.0 points a game this season.

    She is on pace to break Plum’s mark against Michigan on Feb. 15.

    LAST TIME OUT

    Clark, last year’s AP player of the year, had 38 points in a win over Nebraska on Jan. 27. She also had 10 rebounds and six assists.

    UP NEXT: Iowa at Northwestern

    Clark could move into second place on the all-time scoring list during Wednesday night’s game at Northwestern, which would mean passing Missouri State’s Jackie Stiles (3,393) and Ohio State’s Kelsey Mitchell (3,402). Passing Mitchell would also give Clark the Big Ten scoring mark.

    CLARK STATS

    Clark has scored at least 40 points 11 times in her career, including three this season.

    Clark is also approaching 1,000 career assists as she has 958 and sits in eighth place all-time. She is averaging 7.1 assists per game. She is 29 assists behind former Providence star Shanya Evans for seventh and 30 behind Niya Johnson for sixth. Suzie McConnell of Penn State holds the NCAA record with 1,307.

    WHO ARE THE ALL-TIME LEADING SCORERS?

    Plum holds the women’s record after her standout, four-year career at Washington (2013-17). The all-time college basketball leading scorer is LSU’s Pete Maravich, who finished his career with 3,667 points. He did it with no 3-point line in college basketball and in only three seasons (1967-70); freshmen at that point weren’t allowed to play on varsity teams.

    The Associated Press contributed to this report.

    Copyright © 2024 WLS-TV. All Rights Reserved.



    John Garcia

    Source link

  • Rubber behavior: Dynamics decoded

    Rubber behavior: Dynamics decoded

    New device could improve the outcomes of cell-based therapies

    Northwestern University

    Source link

  • Doctors Suddenly Got Way Better at Treating Eczema

    Doctors Suddenly Got Way Better at Treating Eczema

    Up until a few years ago, Heather Sullivan’s 14-year-old son, Sawyer, had struggled with eczema his entire life. When he was just a baby, most of his body would be covered in intensely itchy rashes that bled and oozed when he couldn’t help but scratch. His family tried steroid creams, wet wraps, bleach baths, and all of the lotions. They tore up their carpet and replaced their sheetrock in hopes of eliminating triggers. At 15 months, he went on cyclosporine, a powerful immunosuppressant usually given to organ-transplant patients. It cleared him up, but the drug comes with potentially dangerous side effects over time. Doctors, Sullivan recalls, were “just appalled that my child would be on this amount of medicine at this age”—but his eczema came roaring back as soon as he went off it.

    When a new eczema drug called Dupixent finally became available to Sawyer a few years ago, his turnaround was fast and dramatic. Within a week, his itchiness and redness started calming down. He felt and looked better. The condition that had dominated their lives began to fade into the background.

    Doctors who treat severe eczema now speak of pre- and post-Dupixent eras: “It changed the landscape of having eczema forever,” says Brett King, a dermatologist at Yale. Today, a half dozen novel treatments are available for the skin condition, all of which work by quieting the same biological pathway in eczema; dozens more are in clinical trials. Unlike older drugs, these new ones are precisely targeted and in many cases startlingly effective.

    Eczema, also known as atopic dermatitis, is characterized by red, itchy, and inflamed skin. It’s a very common condition, estimated to affect 10 percent of Americans. Of those, a large minority suffer from moderate to severe eczema that seeps into everyday life. “Just imagine scratching endlessly,” King says. “You wake up from sleep scratching. Your sheets are bloody in the morning.” The most basic eczema advice is to moisturize, and moisturize often, to protect the barrier of the skin. But scientists now know that eczema’s cause is not in the skin alone. Many patients also have “an over-reactive or overzealous immune system,” says Dawn Davis, a dermatologist at the Mayo Clinic. Their immune cells release chemicals that irritate nerves, causing itch, and even degrade the skin itself.

    Topical steroids, such as over-the-counter hydrocortisone cream, can tamp down the immune reaction that flares in eczema. If these fail, doctors have resorted to more powerful oral steroids, such as prednisone, or other oral immunosuppressants, such as the aforementioned cyclosporine. The drugs can calm eczema, but because they suppress the overall immune system, they also do much more. Prednisone, for example, makes you more prone to infections as well as bone fractures, high blood pressure, and glaucoma when taken in the long term. Of course, for many people, eczema is a chronic condition that requires long-term treatment. “Prednisone is kind of like carpet bombing,” says Peter Lio, a dermatologist at Northwestern University. It blasts eczema away, but at a cost.

    In contrast, the newer drugs, Lio says, are more like shotguns that target specific parts of the immune system—with less collateral damage. They fall into two broad classes. Monoclonal antibodies, such as Dupixent, intercept the immune-signaling molecules that trigger itch and skin inflammation. And then JAK inhibitors, which include pills such as Rinvoq and the topical cream Opzelura, scramble the signal after cells have received it. The development of these drugs came after years of research zeroed in on some of the key immune molecules dysregulated in eczema. But serendipity played a role too: The first such drugs were originally developed for other conditions, such as rheumatoid arthritis—only to be repurposed when researchers realized that they targeted the very pathways involved in eczema. The breakthroughs in eczema treatment, in fact, are part of a broader revolution in treating inflammatory disorders; both classes of new drugs are now used to tune the immune system in a whole host of different conditions.

    The monoclonal antibodies and oral JAK inhibitors may have their own serious side effects, such as blood clots, which, Lio says, give some doctors unfamiliar with the new drugs—especially the latter type—pause. But the traditional drugs are not great either. “I’m frustrated that a lot of clinicians are very cavalier about prednisone and cyclosporine … They’re like, ‘Oh, they’re our old friends,’” he told me. “Then they get nervous about JAK inhibitors.” In his mind, the new drugs are simply the better option in terms of safety and efficacy.

    Jonathan Silverberg, a dermatologist at George Washington University who specializes in eczema, says he now rarely uses the old oral steroids and immunosuppressants. When he does revert to them, it’s not for medical reasons: He ends up prescribing older (that is, generic and therefore cheaper) drugs for uninsured patients who can’t afford the new ones, or for patients who have insurance but are nevertheless denied coverage. “Insurance says, ‘Can it be fixed with a $10 medicine? Or does it really need the $1,000 tube?’” King told me. Getting patients these newer drugs can mean a lot of time fighting with insurance.

    For now, these drugs have most dramatically improved the lives of patients with moderate to severe eczema—at least those patients who can access them. But doctors told me that topical JAK inhibitors, which are safer than the oral version, could one day be first-line treatments for mild eczema as well. “In a perfect world, I would love it if I never had to prescribe a topical steroid again,” Silverberg said, citing the side effects that come with long-term use. Topical steroids can thin the skin, causing stretch marks, fragility, and poor healing. But at the moment, steroids are also cheap and easily available. They’re not going anywhere as long as the new treatments still come with hefty price tags.

    Sarah Zhang

    Source link

  • First lawsuit filed against Pat Fitzgerald, Northwestern leaders amid hazing scandal

    First lawsuit filed against Pat Fitzgerald, Northwestern leaders amid hazing scandal

    A lawsuit has been filed against Northwestern University leaders and former head football coach Pat Fitzgerald amid allegations of hazing on the football team. It is the first lawsuit related to the scandal, which has already seen Fitzgerald lose his job

    The lawsuit, filed on Tuesday, said hazing activities were “assaultive, illegal and often sexual in nature.” The player the lawsuit is on behalf of was a member of the team from 2018 to 2022, and was “among many others who have been subjected to sexualized hazing and physical abuse while they were part of the Northwestern Athletic Program.” 

    Also named in the lawsuit are Northwestern University president Michael Schill, former university president Morton Schapiro, Vice President for Athletics and Recreation Dr. Derrick Gragg, and the university’s board of trustees. Those parties, as well as Fitzgerald, were described in the complaint as having “extensive, far-reaching, and ongoing complicity and involvement in the systemic abuse” of Northwestern student athletes. 

    An investigation into the hazing allegations was launched in Dec. 2022, after an anonymous complaint alleged that players engage in hazing activities in the locker room. Dozens of people affiliated with the Wildcats football program were interviewed, and thousands of emails and player survey data was collected, according to CBS Chicago. The investigation did not uncover specific misconduct by any one player or coach, and Fitzgerald said he was not aware of any hazing on the team. 

    After the investigation, Fitzgerald was suspended for two weeks, but later returned to his position. The school also discontinued the team’s Wisconsin training camp, where some of the hazing was alleged to have occurred, and instituted other policies meant to reduce hazing.

    An article by student newspaper The Daily Northwestern, published on July 8, shared a student and football player’s account of alleged hazing activities. The student said the practices “involved coerced sexual acts,” and said Fitzgerald “may have known that hazing took place.” 

    Fitzgerald was later fired, and he told ESPN last week he had “no knowledge whatsoever of any form of hazing within the Northwestern football program.”

    Northwestern University said they have a policy against commenting on specifics of pending litigation, but defended their actions in the investigation and said that they have “taken a number of subsequent actions to eliminate hazing from our football program, and we will introduce additional actions in the coming weeks.” 

    CBS News has reached out to Fitzgerald for comment through his attorney.


    Amid hazing scandal, former Northwestern athletes retain attorneys

    02:53

    Tuesday’s lawsuit outlined multiple alleged hazing activities, including one called “Runs” where young players who made a mistake would allegedly be dry-humped by members of the team. A hand motion, called the “Shrek clap” in the lawsuit, would be used to signify that a player was about to be targeted, and according to the suit, Fitzgerald himself “was seen on multiple occasions performing” the clap. Many other hazing activities included players being naked while harassing their teammates, the suit alleges.  

    According to the lawsuit, “knowledge and involvement in the aforementioned traditions was widespread throughout the entire football program.”

    The suit has filed two counts against Fitzgerald and other leaders. One count alleges that the leaders “failed to prevent hazing traditions,” failed to intervene in and report on such behaviors, and failed to protect students from acts that were “assaultive, illegal, and often sexual in nature.” 

    The leaders were also accused of failing to supervise practices and locker rooms, failing to properly train and supervise staff and employees in the performance of duties and policies about misconduct, hazing and racism, and reviewing those employees’ performance and actions. 

    The second count alleges that the defendants “knew or should have known about the traditions of hazing throughout Northwestern’s Football Program,” and “knew or should have known” that failing to supervise students would lead to such results. The suit also alleges that Fitzgerald and other leaders “knew or should have known that bullying and/or hazing was so prevalent that unwilling participants were forced to take part” in the activities. 

    The plaintiff is asking for at least $50,000 in damages for each count, and has demanded a trial by jury. 

    In a 2014 video, Fitzgerald said his program had a zero tolerance policy for hazing. 

    “We’ve really thought deep about how we want to welcome our new family members into our programs and into our organizations, hazing should have nothing to do with it,” he said at the time.

    Source link

  • Northwestern football coach fired amid accusations of hazing in the program

    Northwestern football coach fired amid accusations of hazing in the program

    Northwestern football coach fired amid accusations of hazing in the program – CBS News


    Watch CBS News



    Northwestern football coach Pat Fitzgerald was fired Monday amid allegations of hazing within the program. Jericka Duncan reports.

    Be the first to know

    Get browser notifications for breaking news, live events, and exclusive reporting.


    Source link

  • Life Is Worse for Older People Now

    Life Is Worse for Older People Now

    Last December, during a Christmas Eve celebration with my in-laws in California, I observed what I now realize was the future of COVID for older people. As everyone crowded around the bagna cauda, a hot dipping sauce shared like fondue, it was clear that we, as a family, had implicitly agreed that the pandemic was over. Our nonagenarian relatives were not taking any precautions, nor was anyone else taking precautions to protect them. Endive spear in hand, I squeezed myself in between my 94-year-old grandfather-in-law and his spry 99-year-old sister and dug into the dip.

    We all knew that older people bore the brunt of COVID, but the concerns seemed like a relic from earlier in the pandemic. The brutal biology of this disease meant that they disproportionately have fallen sick, been hospitalized, and died. Americans over 65 make up 17 percent of the U.S. population, but they have accounted for three-quarters of all COVID deaths. As the death count among older people began to rise in 2020, “a lot of my patients were really concerned that they were being exposed without anyone really caring about them,” Sharon Brangman, a geriatrician at SUNY Upstate University Hospital, told me.

    But even now, three years into the pandemic, older people are still in a precarious position. While many Americans can tune out COVID and easily fend off an infection when it strikes, older adults continue to face real threats from the illness in the minutiae of their daily life: grocery trips, family gatherings, birthday parties, coffee dates. That is true even with the protective power of several shots and the broader retreat of the virus. “There is substantial risk, even if you’ve gotten all the vaccines,” Bernard Black, a law professor at Northwestern University who studies health policy, told me. More than 300 people still die from COVID each day, and the overwhelming majority of them are older. People ages 65 and up are currently hospitalized at nearly 11 times the rate of adults under 50.

    Compounding this sickness are all the ways that, COVID aside, this pandemic has changed life for older adults. Enduring severe isolation and ongoing caregiver shortages, they have been disproportionately harmed by the past few years. Not all of them have experienced the pandemic in the same way. Americans of retirement age, 65 and older, are a huge population encompassing a range of incomes, health statuses, living situations, and racial backgrounds. Nevertheless, by virtue of their age alone, they live with a new reality: one in which life has become more dangerous—and in many ways worse—than it was before COVID.


    The pandemic was destined to come after older Americans. Their immune systems tend to be weaker, making it harder for them to fight off an infection, and they are more likely to have comorbidities, which further increases their risk of severe illness. The precarity that many of them already faced going into 2020—poverty, social isolation and loneliness, inadequate personal care—left them poorly equipped for the arrival of the novel coronavirus. More than 1 million people lived in nursing homes, many of which were densely packed and short on staff when COVID tore through them.

    A major reason older people are still at risk is that vaccines can’t entirely compensate for their immune systems. A study recently published in the journal Vaccines showed that for vaccinated adults ages 60 and over, the risk of dying from COVID versus other natural causes jumped from 11 percent to 34 percent within a year of completing their primary shot series. A booster dose brings the risk back down, but other research shows that it wears off too. A booster is a basic precaution, but “not one that everyone is taking,” Black, a co-author of the study, told me. Booster uptake among older Americans for the reengineered “bivalent” shots is the highest of all age groups, but still, nearly 60 percent have not gotten one.

    For every COVID death, many more older people develop serious illness. Risk increases with age, and people older than 70 “have a substantially higher rate of hospitalizations” than those ages 60 to 69, Caitlin Rivers, an epidemiologist at Johns Hopkins University, told me. Unlike younger people, most of whom fully recover from a bout with COVID, a return to baseline health is less guaranteed for older adults. In one study, 32 percent of adults over 65 were diagnosed with symptoms that lasted well beyond their COVID infection. Persistent coughs, aches, and joint pain can linger long after serious illness, together with indirect impacts such as loss of muscle strength and flexibility, which can affect older people’s ability to be independent, Rivers said. Older COVID survivors may also have a higher risk of cognitive decline. In some cases, these ailments could be part of long COVID, which may be more prevalent in older people.

    Certainly, some older adults are able to make a full recovery. Brangman said she has “old and frail” geriatric patients who bounced back after flu-like symptoms, and younger ones who still experience weakness and fatigue. Still, these are not promising odds. The antiviral Paxlovid was supposed to help blunt the wave of old people falling sick and ending up in the hospital—and it can reduce severe disease by 50 to 90 percent. But unfortunately, it is not widely used; as of July, just a third of Americans 80 or older took Paxlovid.

    The reality is that as long as the virus continues to be prevalent, older Americans will face these potential outcomes every time they leave their home. That doesn’t mean they will barricade themselves indoors, or that they even should. Still, “every decision that we make now is weighing that balance between risk and socialization,” Brangman said.


    Long before the pandemic, the threat of illness was already very real for older people.  Where America has landed is hardly a new way of life but rather one that is simply more onerous. “One way to think about it is that this is a new risk that’s out there” alongside other natural causes of death, such as diabetes and heart failure, Black said. But it’s a risk older Americans can’t ignore, especially as the country has dropped all COVID precautions. Since Christmas Eve, I have felt uneasy about how readily I normalized putting so little effort into protecting my nonagenarian loved ones, despite knowing what might happen if they got sick. For older people, who must contend with the peril of attending similar gatherings, “there’s sort of no good choice,” Black said. “The world has changed.”

    But this new post-pandemic reality also includes insidious effects on older people that aren’t directly related to COVID itself. Those who put off nonemergency visits to the doctor earlier in the pandemic, for example, risked worsening their existing health conditions. The first year of the pandemic plunged nearly everyone into isolation, but being alone created problems for older adults that still persist. Before the pandemic, the association between loneliness and higher mortality rates, increased cardiovascular risks, and dementia among older adults was already well established. Increased isolation during COVID amplified this association.

    The consequences of isolation were especially profound for older adults with physical limitations, Naoko Muramatsu, a community-health professor at the University of Illinois at Chicago, told me. When caregivers or family members were unable to visit, people who required assistance for even the smallest tasks, such as fetching the mail and getting dressed, had no options. “If you don’t walk around and if you don’t do anything, we can expect that cognitive function will decline,” Muramatsu said; she has observed this firsthand in her research. One Chinese American woman, interviewed in a survey of older adults living alone with cognitive impairment during the pandemic, described the debilitating effect of sitting at home all day.“I am so useless now,” she told the interviewer. “I am confused so often. I forget things.”

    Even older adults who have weathered the direct and indirect effects of the pandemic still face other challenges that COVID has exacerbated. Many have long relied on personal caregivers or the staff at nursing facilities. These workers, already scarce before the pandemic, are even more so now because many quit or were affected by COVID themselves. “Long-term care has been in a crisis situation for a long time, but it’s even worse now,” Muramatsu said, noting that many home care workers are older adults themselves. Nursing homes nationwide now have nearly 200,000 fewer employees compared with March 2020, which is especially concerning as the proportion of Americans over age 65 explodes.

    Older people won’t have one single approach to contending with this sad reality. “Everybody is trying to figure out what is the best way to function, to try to have some level of everyday life and activity, but also keep your risk of getting sick as low as possible,” Brangman said. Some of her patients are still opting to be cautious, while others consider this moment their “only chance to see grandchildren or concerts or go to family gatherings.” Either way, older Americans will have to wrestle with these decisions without so many of their peers who have died from COVID.

    Again, many of these people did not have it great before the pandemic, even if the rest of the country wasn’t paying attention. “We often don’t provide the basic social support that older people need,” Kenneth Covinsky, a clinician-researcher at the UCSF Division of Geriatrics, said. Rather, ageism, the willful ignorance or indifference to the needs of older people, is baked into American life. It is perhaps the main reason older adults were so badly affected by the pandemic in the first place, as illustrated by the delayed introduction of safety precautions in nursing homes and the blithe acceptance of COVID deaths among older adults. If Americans couldn’t bring themselves to care at any point over the past three years, will they ever?

    Yasmin Tayag

    Source link

  • A surprising way to trap a microparticle

    A surprising way to trap a microparticle

    • New study finds obstacles can trap rolling microparticles in fluid
    • Through simulations and experiments, physicists attribute the trapping effect to stagnant pockets of fluid, created by hydrodynamics
    • Random motions of the molecules within the fluid then ‘kick’ the microroller into a stagnant pocket, effectively trapping it
    • Size of the obstacle also controls how easy it is to trap a microroller and how long it remains trapped

    Newswise — EVANSTON, Ill. — When physicists steered a tiny microparticle toward a cylindrical obstacle, they expected one of two outcomes to occur. The particle would either collide into the obstacle or sail around it. The particle, however, did neither.

    The researcher team — led by Northwestern University and École Polytechnique in France — was surprised and puzzled to watch the particle curve around the obstacle and then stick to its backside. The obstacle, it seemed, had the particle effectively trapped.

    After a series of simulations and experiments, the researchers unraveled the physics at play behind this strange phenomenon. Three factors caused the unexpected trapping behavior: electrostatics, hydrodynamics and erratic random movement of the surrounding molecules. The size of the obstacle also determined how long the particle remained trapped before escaping.

    The new insights could be leveraged to advance microfluidic applications and drug delivery systems — both of which rely on microparticles to navigate complex, structured landscapes.

    The study will be published March 8 in the journal Science Advances.

    “I didn’t expect to see trapping in this system at all,” said Northwestern’s Michelle Driscoll, who co-led the study. “But trapping adds a lot of utility to the system because now we have a way to gather up particles. Tasks like trapping, mixing and sorting are very difficult to do at such small scales. You can’t just scale down standard processes for mixing and sorting because a different kind of physics kicks in at this size limit. So, it’s important to have different ways to manipulate particles.”

    Driscoll is an assistant professor of physics at Northwestern’s Weinberg College of Arts and Sciences. She co-led the study with Blaise Delmotte, a researcher at École Polytechnique.

    Similar in size to bacteria, microrollers are synthetic, microscopic particles with the ability to move in a fluid environment. Driscoll and her team are particularly interested in microrollers for their ability to move freely — and quickly — in different directions and their potential to carry and deliver cargo in complex, confined environments, including within the human body.

    The microrollers in Driscoll’s lab are plastic with an iron oxide core, which gives them a weak magnetic field. By putting the microrollers in a sealed microchamber (100 millimeters by 2 millimeters by 0.1 millimeters in size), researchers can control the direction they move by manipulating a rotating magnetic field around the sample. To change the way the microrollers move, researchers simply reprogram the motion of the magnetic field to pull the microrollers in different directions.

    But microfluidic devices and the human body are, of course, much more complex landscapes compared to a featureless sample chamber. So, Driscoll and her collaborators added obstacles to the system to see how microrollers could navigate the environment.

    “For true-to-life applications, you aren’t just going to have this system with particles sitting in an open space,” Driscoll said. “It’s going to be a complex landscape. You might have to move the particles through winding channels. So, we wanted to first explore the simplest version of the problem: One microroller and one obstacle.”

    In both computer simulations and the experimental environment, Driscoll and her team added cylindrical obstacles to the sample chamber. Sometimes the microroller sailed around the obstacle without issue, but other times it would swing around the obstacle and then get trapped behind it.

    “We watched the particle stop moving past the obstacle and kind of get stuck,” Driscoll said. “We saw the same behavior in the simulations and in the experiments.”

    By changing the parameters within the simulations and analyzing the data, Driscoll and her team found the hydrodynamics of the fluid inside the sample chamber created stagnant areas. In other words, the spinning microroller caused the fluid to flow in the chamber. But the flows also created pockets — including one directly behind the obstacle — where the fluid remained still and unflowing. When the particle entered the stagnant area, it stopped moving and became stuck.

    But to reach the stagnant area, the particle had to perform a baffling U-turn. After moving past the obstacle, the microroller curved around it, becoming stuck to its backside. Driscoll found that random motions (called Brownian motion) of the molecules within the fluid “kicked” the microroller into the stagnant area.

    “Tiny materials are subject to Brownian fluctuations,” Driscoll explained. “The fluid is not actually a continuum but is composed of individual, little molecules. Those molecules are constantly ramming into the particle at random orientations. If the particle is small enough, these collisions can move it. That’s why if you look at tiny particles under a microscope, they look like they are juggling around a little bit.”

    Driscoll’s team also found that the size of the obstacle controls how long the particle will remain trapped before escaping. For example, it’s easier for Brownian fluctuations to kick the particle into the trapping region when the obstacle is smaller. By changing the obstacle size, researchers can increase the trapping time by orders of magnitude.

    “Usually, Brownian fluctuations are destructive to experiments because they are a source of noise,” Driscoll said. “Here, we can leverage Brownian motion to do something useful. We can enable this hydrodynamic trapping effect.”

    The study, “A simple catch: Fluctuations enable hydrodynamic trapping of microrollers by obstacles,” was supported by the National Science Foundation under award number CBET-1706562, “la Caixa” Foundation (award numbers 100010434 and fellowship LCF/BQ/-PI20/11760014), the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant (award number 847648), the French National Research Agency (award number ANR- 20-CE30-0006) and the NVIDIA Academic Partnership.

    Northwestern University

    Source link

  • What Do Big Tech Layoffs Mean for STEM Programs?

    What Do Big Tech Layoffs Mean for STEM Programs?

    One of the hottest fields for recent college graduates has recently cooled off, as layoffs have hit the technology sector.

    On Tuesday, Zoom announced it will be eliminating 15 percent of its staff. Spotify, Amazon, Google, and Microsoft have all made cuts in their work forces in the past month. In November, the Facebook parent company Meta announced it would be cutting 13 percent of its workers. Amazon and Google are also expected to hire fewer interns in 2023 than in past years.

    It is being called the largest wave of tech layoffs since the dot-com crash in the early 2000s, and it’s creating headaches for colleges’ career-counseling offices and soon-to-be-graduates who flocked to majors that once promised plentiful jobs.

    For the past two decades, colleges, think tanks, and policy makers have touted the wage-earning potential of science, technology, engineering, and mathematics degree programs. Enrollments in many of those fields have grown accordingly, particularly in computer science.

    The number of students pursuing bachelor’s degrees in computer and information sciences and support services has increased by 34 percent since 2017, according to data from the National Student Clearinghouse Research Center.

    Interest in data science has risen as well. The Bureau of Labor Statistics projects that demand for data scientists will rise by 36 percent, much faster than the average for all occupations, from 2021 to 2031.

    If history is any guide, it will most likely take some time for students and undergraduate academic programs to adjust to the changing job market.

    The number of undergraduate computer-science degrees conferred in the United States began rising in 1995-96 and continued to do so until just after the dot-com bubble burst in the early 2000s. That started affecting freshmen’s choices. By 2005-6, the number of computer-science degrees as a share of all degrees awarded dropped to 3.2 percent from 3.5 percent in 2000-1. The Great Recession dealt a further blow to the field, as computer-science degrees made up only 2.5 percent of all degrees earned in 2010-11.

    Since then, the share of such degrees conferred has grown each year, reaching almost 5 percent in 2019-20.

    It’s just a matter of researching the employers that are engaging with the campus, as opposed to pining away for the ones that maybe aren’t at the moment

    The drop in enrollment after the dot-com bubble burst was felt on campuses in many ways, said Amruth Kumar, professor of computer science at Ramapo College of New Jersey. Classes that were held once a semester were only held once a year, and some courses were combined in an attempt to fill them up.

    Kumar said that he isn’t yet sure what to make of recent tech layoffs. Graduates who are just entering the job market could be disadvantaged by the layoffs and rapid rehiring of tech employees, he said, but the long-term effects on computer science as an academic field remain uncertain.

    Besides, computer-science departments may face more immediate threats to their enrollment, and they come from within the campus. Soaring interest in data-science programs could divert institutional resources and draw students. Kumar said that while the increased interest in data science could cause a slight decline in computer-science enrollment, the two areas focus on different ways of problem-solving with technology.

    “It seems to me that data science caters to a different skill set than computer science,” said Kumar, who is co-chair of CS 2023, a multi-association effort to create curricular guidelines for computer-science programs across the world.

    Kumar believes computer science has become so popular because of the myriad fields computers are now used in.

    “It used to be the case that only people use them in STEM disciplines, but now you have computer science being used for communication, social interaction like Facebook and Twitter,” he said. “All these are nothing but computer-science products appealing to other areas, other walks of life.”

    Undergrad Programs Forge Ahead

    For now, undergraduate programs across the country remain optimistic about interest in their disciplines and students’ job prospects.

    The College of William & Mary plans to expand its data-science program; data is one of the four tenets of its “Vision 2026” plan. That’s because data fluency is a skill that students can apply in a variety of industries, said Kathleen Powell, chief career officer at William & Mary.

    “Our students are understanding that if they’re combining that data fluency with strong communication skills, strong critical-thinking skills, that is actually opening up pathways for different types of internships and full-time opportunities,” Powell said.

    She’s confident most 2023 graduates will find jobs. Companies plan to hire 14.7 percent more graduates from the Class of 2023 than were hired from the Class of 2022, according to a report by the National Association of Colleges and Employers.

    For their part, students seem to be optimistic, too. Full career fairs and continued demand from companies that are not tech giants may be giving them a false sense of security amid a possible economic downturn.

    “It takes about six months for students to realize that, you know, maybe the job market isn’t as great,” said Gail Cornelius, director of the career center at the University of Washington’s College of Engineering. “It’s also somewhat deceiving in the fact that when we have our career-fair employer activities on campus, we are still full.”

    The fairs still attract between 70 and 100 employers, she said, and she hasn’t noticed companies rescinding offers made to students, though some employers have delayed students’ start dates.

    Students at Washington have flocked to computer science in recent years. In 2017, the university created a school of computer science, the Paul G. Allen School of Computer Science and Engineering. Since then, the number of undergraduate students enrolled in the university’s computer-science program at its Seattle campus has more than doubled. At the start of the winter quarter in January, the university’s Seattle campus had over 1,500 undergraduate computer-science majors. As of the autumn-2022 quarter, computer science was the most popular major at all three University of Washington campuses.

    Many graduates have gone on to jobs at tech companies. About 55 percent of engineering graduates from the university got jobs with large technology companies, said Cornelius, citing data collected by the career center. And 44 percent of graduates found jobs with roughly 500 other companies, including those in nontechnology industries.

    “Our students are savvy enough to know that even though I didn’t get the Amazon job, the first job I get out of school isn’t going to be the dream job, and isn’t going to be the place that I die in,” Cornelius said.

    Closer to Silicon Valley, career counselors are advising students to be flexible in their career choices.

    “There’s always companies and industries that are going to be thriving depending on what the market is,” said Kelly Masegian, a technology and engineering career counselor at San Jose State University. “It’s just a matter of finding those, and figuring out how you can pitch your skills in those environments.”

    For example, Masegian and her colleagues are trying to introduce students to technology fields seeing major investments, like the semiconductor industry.

    Like Cornelius in Washington, Masegian hasn’t seen job offers to new grads being rescinded, but she has seen some delays. Masegian said about 85 students who received job offers from Amazon had their start date postponed by six months. Many of them are international students, she said, whose ability to remain in the United States hinges on being employed within 90 days of graduating.

    Despite the delayed starts for some students, Masegian said, she hasn’t seen companies reducing their hiring. Over 125 employers have signed up for the university’s upcoming STEM career fair, which can accommodate only 80 companies.

    “It’s just a matter of researching the employers that are engaging with the campus, as opposed to pining away for the ones that maybe aren’t at the moment,” Masegian said.

    She said that some students have been nervous about their ability to get internships, but she tries to remind them of the nature of the internship market. Students vying for internships are not competing with recently laid-off professionals, most of whom have years of experience.

    Even recent graduates seeking entry-level positions might not be competing with recently laid-off workers, she said, because of differences in their experience levels.

    A Market for M.B.A. Programs

    If the changing nature of the tech job market poses a challenge for undergraduate programs, it’s looking like an opportunity for graduate business programs. Some M.B.A. programs are seeking to capitalize on the layoffs, redirecting their recruiting efforts toward unemployed technology workers.

    In November, some business schools started waiving fees and testing requirements for applicants to M.B.A. programs who can provide proof of being recently laid off.

    For example, the S.C. Johnson Graduate School of Management at Cornell University has waived GMAT or GRE requirements and application fees for laid-off tech workers. The University of California at Berkeley’s Haas School of Business waived its application fee and extended the deadline to apply for its full-time M.B.A. program. Santa Clara University’s Leavey School of Business is waiving application fees and test requirements, as well as promising some prospective students a minimum $3,000 scholarship.

    Workers with STEM backgrounds are attractive prospective M.B.A. students because of the skills they’ve picked up in the workplace, said Greg Hanifee, associate dean of degree operations at Northwestern University’s Kellogg School of Management, which announced it was waiving testing requirements in November.

    Our students are savvy enough to know that even though I didn’t get the Amazon job, the first job I get out of school isn’t going to be the dream job, and isn’t going to be the place that I die in

    Hanifee said Kellogg decided to waive GMAT scores and market to those experiencing tech layoffs out of a sense of empathy for tech workers whose sudden layoffs meant they may not have had much time to study for exams. Kellogg will continue evaluating the economy to determine whether it will waive the exam for next year’s class.

    He also said that the high hiring standards of major tech companies, like Meta and Google, mean laid-off workers are strong candidates, even without graduate exam scores supporting their applications.

    “I think we’re at the point now where, fingers crossed, the economy rebounds from some of this, and there aren’t additional sectors that go through a similar sort of mass layoff experience,” Hanifee said.

    And, while some displaced tech workers may find refuge in an M.B.A. program, many may well be headed right back into the field after earning their graduate degrees. Twenty-four percent of Kellogg’s full-time graduates in 2022 found employment in the technology industry.

    The ranks of the newly unemployed may fill a need for M.B.A. programs, said Martin Van Der Werf, director of editorial and education policy at Georgetown University’s Center for Education and the Workforce, and a former Chronicle editor.

    Many M.B.A. programs are facing enrollment declines similar to those plaguing institutions across the country. The U.S. is home to over 500 colleges with masters programs accredited by the Association to Advance Collegiate Schools of Business.

    Applications for admission to graduate business schools increased only by 0.4 percent from 2020 to 2021, a far cry from the average annual increase of 3.6 percent from 2016 to 2020, according to a report by the Council of Graduate Schools.

    The report also says that overall enrollment in graduate business programs declined by 3.4 percent from 2020 to 2021. During that period, part-time enrollment for first-time graduate students fell by 15.6 percent, while full-time enrollment for first-time students rose by 4.1 percent.

    “They’re looking to fill as many seats as they can,” said Van Der Werf.

    Kate Marijolovic

    Source link

  • Vertical electrochemical transistor pushes wearable electronics forward

    Vertical electrochemical transistor pushes wearable electronics forward

    Newswise — A transdisciplinary Northwestern University research team has developed a revolutionary transistor that is expected be ideal for lightweight, flexible, high-performance bioelectronics.

    The electrochemical transistor is compatible with blood and water and can amplify important signals, making it especially useful for biomedical sensing. Such a transistor could enable wearable devices for onsite signal processing, right at the biology-device interface. Potential applications include measuring heartbeat and levels of sodium and potassium in blood as well as eye motion for studying sleep disorders.

    “All modern electronics use transistors, which rapidly turn current on and off,” said Tobin J. Marks, a co-corresponding author of the study. “Here we use chemistry to enhance the switching. Our electrochemical transistor takes performance to a totally new level. You have all the properties of a conventional transistor but far higher transconductance (a measure of the amplification it can deliver), ultra-stable cycling of the switching properties, a small footprint that can enable high density integration, and easy, low-cost fabrication.”

    Marks is a world leader in the fields of materials science and organic electronics. He is the Vladimir N. Ipatieff Professor of Catalytic Chemistry in the Weinberg College of Arts and Sciences and professor of materials science and engineering and chemical and biological engineering in the McCormick School of Engineering.

    The vertical electrochemical transistor is based on a new kind of electronic polymer and a vertical, instead of planar, architecture. It conducts both electricity and ions and is stable in air. The design and synthesis of new materials and the transistor’s fabrication and characterization required the collaborative expertise of chemists, materials scientists and biomedical engineers.

    Marks led the research team along with Antonio Facchetti, research professor of chemistry at Weinberg; Wei Huang, now a professor at the University of Electronic Science and Technology of China; and Jonathan Rivnay, professor of biomedical engineering at the McCormick School.

    “This exciting new type of transistor allows us to speak the language of both biological systems, which often communicate via ionic signaling, and electronic systems, which communicate with electrons,” Rivnay said. “The ability of the transistors to work very efficiently as ‘mixed conductors’ makes them attractive for bioelectronic diagnostics and therapies.”

    This study detailing the efficient electrochemical transistor and an accompanying News & Views article were published this week by the journal Nature.

    “With their vertical architecture, our electrochemical transistors can be stacked one on top of another,” Facchetti said. “Thus, we can make very dense electrochemical complementary circuits, which is impossible for the conventional planar electrochemical transistors.”

    To make more reliable and powerful electronic circuits, two types of transistors are needed: p-type transistors that carry positive charges and n-type transistors that carry negative charges. These types of circuits are called complementary circuits. The challenge researchers have faced in the past is that n-type transistors are difficult to build and are typically unstable.

    This is the first work to demonstrate electrochemical transistors with similar and very high performance for both types (p+n) electrochemical transistors. This resulted in the fabrication of very efficient electrochemical complementary circuits. 

    The study is entitled “Vertical organic electrochemical transistors for complementary circuits.” Huang, Jianhua Chen and Yao Yao are co-first authors.

    Northwestern University

    Source link